rs12430077

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001365552.1(NEK5):​c.*1876A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0226 in 151,562 control chromosomes in the GnomAD database, including 182 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.023 ( 181 hom., cov: 31)
Exomes 𝑓: 0.33 ( 1 hom. )

Consequence

NEK5
NM_001365552.1 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.02

Publications

3 publications found
Variant links:
Genes affected
NEK5 (HGNC:7748): (NIMA related kinase 5) Predicted to enable ATP binding activity; metal ion binding activity; and protein kinase activity. Predicted to be involved in protein phosphorylation. Predicted to act upstream of or within positive regulation of cysteine-type endopeptidase activity and positive regulation of striated muscle cell differentiation. [provided by Alliance of Genome Resources, Apr 2022]
ALG11 (HGNC:32456): (ALG11 alpha-1,2-mannosyltransferase) This gene encodes a GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase which is localized to the cytosolic side of the endoplasmic reticulum (ER) and catalyzes the transfer of the fourth and fifth mannose residue from GDP-mannose (GDP-Man) to Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol resulting in the production of Man5GlcNAc2-PP-dolichol. Mutations in this gene are associated with congenital disorder of glycosylation type Ip (CDGIP). This gene overlaps but is distinct from the UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast) gene. A pseudogene of the GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase has been identified on chromosome 19. [provided by RefSeq, Aug 2010]
ALG11 Gene-Disease associations (from GenCC):
  • ALG11-congenital disorder of glycosylation
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, ClinGen, Ambry Genetics, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEK5NM_001365552.1 linkc.*1876A>G 3_prime_UTR_variant Exon 24 of 24 ENST00000684899.1 NP_001352481.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEK5ENST00000684899.1 linkc.*1876A>G 3_prime_UTR_variant Exon 24 of 24 NM_001365552.1 ENSP00000509632.1 A0A8I5KQI9

Frequencies

GnomAD3 genomes
AF:
0.0225
AC:
3412
AN:
151440
Hom.:
180
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00379
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0616
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.195
Gnomad SAS
AF:
0.00981
Gnomad FIN
AF:
0.0776
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00596
Gnomad OTH
AF:
0.0235
GnomAD4 exome
AF:
0.333
AC:
2
AN:
6
Hom.:
1
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
1.00
AC:
2
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
2
Other (OTH)
AF:
0.00
AC:
0
AN:
2
GnomAD4 genome
AF:
0.0226
AC:
3419
AN:
151556
Hom.:
181
Cov.:
31
AF XY:
0.0266
AC XY:
1972
AN XY:
74040
show subpopulations
African (AFR)
AF:
0.00381
AC:
157
AN:
41230
American (AMR)
AF:
0.0617
AC:
940
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3466
East Asian (EAS)
AF:
0.195
AC:
1001
AN:
5132
South Asian (SAS)
AF:
0.00961
AC:
46
AN:
4786
European-Finnish (FIN)
AF:
0.0776
AC:
814
AN:
10484
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00596
AC:
405
AN:
67924
Other (OTH)
AF:
0.0252
AC:
53
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
148
296
445
593
741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0265
Hom.:
65
Bravo
AF:
0.0234
Asia WGS
AF:
0.0770
AC:
267
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.27
DANN
Benign
0.32
PhyloP100
-2.0

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12430077; hg19: chr13-52609208; API